Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BHRB | RYZ |
|---|---|---|
| Price | $69.28 | $26.97 |
| Change today | ▼ 0.83% | ▲ 5.48% |
| Market cap | $1.40B | $1.40B |
| Return, 3 months | +0.1% | +6.3% |
| Return, year to date | +13.9% | +8.7% |
| Return, 1 year | +16.4% | +17.5% |
| P/E (TTM) | 11.3 | -22.1 |
| P/B | 1.2 | 1.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.18% | 2.78% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 43 | 63 |
| 30-day volatility | 13.9% | 38.3% |
| Max drawdown, 1 year | -13.1% | -34.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
